| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |